Are inflammation-based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma?

被引：2
|
作者：
Huo, Teh-Ia [1 ,2 ,3 ]
Liu, Po-Hong [4 ]
Ho, Shu-Yein [2 ,5 ]
机构：
[1] Taipei Vet Gen Hosp, Dept Med Res, 201,Sec 2,Shipai Rd, Taipei 11217, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei, Taiwan
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[5] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan
来源：
LIVER INTERNATIONAL | 2020年 / 40卷 / 06期
关键词：
HCC; inflammation; prognosis;
D O I：
10.1111/liv.14341
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1498 / 1498
页数：1
相关论文
共 50 条
  • [31] An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib
    R. Diaz-Beveridge
    G. Bruixola
    D. Lorente
    J. Caballero
    E. Rodrigo
    Á. Segura
    D. Akhoundova
    A. Giménez
    J. Aparicio
    Clinical and Translational Oncology, 2018, 20 : 322 - 329
  • [32] Inflammation-Based Prognostic Markers and Outcome of CAPD Patients: Fact or Fiction?
    Schiffl, Helmut
    BLOOD PURIFICATION, 2022, 51 (03) : 296 - 297
  • [33] Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
    Qin, Li
    Li, Chuan
    Xie, Fei
    Wang, Zhenxia
    Wen, Tianfu
    BIOSCIENCE TRENDS, 2020, 14 (04) : 297 - 303
  • [34] NOVEL INFLAMMATION-BASED PROGNOSTIC DETERMINANTS IN PATIENTS WITH CARCINOMA OF UNKNOWN PRIMARY
    Mohamed, Z.
    Pinato, D. J.
    Sharma, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 381 - 381
  • [35] Impact of a novel inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: A retrospective study of 398 Japanese patients
    Ishizuka, M.
    Kubota, K.
    Kita, J.
    Shimoda, M.
    Rokkaku, K.
    Kato, M.
    Sawada, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] The Impact of Inflammation on the Therapeutic Outcome of SBRT in Patients with hepatocellular Carcinoma
    Radicioni, G.
    Exner, J. -P.
    Adebahr, S.
    Haehl, E.
    Spohn, S.
    Ruehle, A.
    Zamboglou, C.
    Sprave, T.
    Nicolay, N. H.
    Grosu, A. -L.
    Gkika, E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S43 - S44
  • [37] Inflammation-Based Prognostic Scores in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Transplantation
    Ren, Ao
    Li, Zhongqiu
    Zhang, Xuzhi
    Deng, Ronghai
    Ma, Yi
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2020, 7 : 101 - 106
  • [38] The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE
    Lu, Liang-He
    Wei-Wei
    Li, Shao-Hua
    Zhang, Yong-Fa
    Guo, Rong-Ping
    AGING-US, 2021, 13 (04): : 5358 - 5368
  • [39] Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
    Mei, Jie
    Sun, Xu-Qi
    Lin, Wen-Ping
    Li, Shao-Hua
    Lu, Liang-He
    Zou, Jing-Wen
    Wei, Wei
    Guo, Rong-Ping
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 3879 - 3890
  • [40] Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation
    Michelle Ong Chu
    Chien-Heng Shen
    Te-Sheng Chang
    Huang-Wei Xu
    Chih-Wei Yen
    Sheng-Nan Lu
    Chao-Hung Hung
    Scientific Reports, 8
12345